Bone Biologics (BBLG) Q1 2026 Earnings
BBLG·Reported May 14, 2026·After market close
Diluted EPS came in at $-0.43 (+77.6% YoY).
Diluted EPS
$-0.43met estimate
Consensus: $-0.43
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Bone Biologics's Q1 2026 earnings report.
Bone Biologics (BBLG) reported Q1 2026 earnings on May 14, 2026 after market close.
Bone Biologics reported diluted EPS of $-0.43 for Q1 2026.
EPS beat the consensus estimate of $-0.43 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 77.6% from $-1.92.
You can read the 10-Q periodic report (0001493152-26-023163) directly on SEC EDGAR. The filing index links above go to sec.gov.